Study on pharmacokinetics of indomethacin in tumor-bearing and normal mice

Chinese Pharmaceutical Journal

Volumn 43, Issue 1, 2008, Pages 48-50

  Dong, Wei ^a   Zhao, Li Mei ^a   Zhang, Cai Xia ^a   Du, Xiao Ming ^a   He, Xiao Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

HPLC; Indomethacin; Lewis lung cancer; Pharmacokinetics

Indexed keywords

INDOMETACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TUMOR LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; SINGLE DRUG DOSE; TUMOR;

EID: 53049095438     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. 3H -in's potential of concentrating to the tumor tissues[J]. J China Nucl Med,2004,(4):209.
2. CAO D S, LIU L P, WANC G J. Study on the preparation of indomethacin sustained-release tablets and its bioavailability [J]. Chin Pharm Univ,2002,33(5):383-387.
3. REMMEL R P, CREWS B C, KOZAK K R, et al. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites [J]. Drug Metab Dispos,2004,32:113-122.
4. YAMADA I, NAGAMATSU Y, IMAYOSHI T, et al. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha, 2-dimethyl-5H-[1] benzopyrano [2,3-b]-pyridine-7-acetate(Y-23023), a new prodrug type of antiinflammatory agent, and indomethacin after oral administrations in rats[J]. Pharmacology,1994,46(7):614-616.
5. LIU S, KAMIJO M, TAKAYASU T, et al. Direct analysis of indomethacin in rat plasma using a column-switching high-performance liquid chromatographic system[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2002,767(1):53-60.